Connection

Bo Cen to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Bo Cen has written about Dose-Response Relationship, Drug.
Bo Cen
Connection Strength
0.036
Dose-Response Relationship, Drug
  1. A bivalent cyclic RGD-siRNA conjugate enhances the antitumor effect of apatinib via co-inhibiting VEGFR2 in non-small cell lung cancer xenografts. Drug Deliv. 2021 Dec; 28(1):1432-1442.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.